Cancer patients struggle with key aspects of clinical trial methodology
LUGANO-MADRID, 10 September, 2017 - Clinical trials are fundamental to the development of new treatments for cancer, yet the annual accrual to cancer clinical trials...
LUGANO-MADRID, 10 September, 2017 - Clinical trials are fundamental to the development of new treatments for cancer, yet the annual accrual to cancer clinical trials...
(Kumamoto University) A recent environmental epidemiological study has shown that Asian sand particles from desert areas of the Asian continent are associated with the onset...
Milan, Italy: New research has shown for the first time that e-cigarettes with nicotine cause a stiffening of the arteries in humans. This has important...
LUGANO-MADRID, 09 September, 2017 -The preliminary results of a study to be presented at the ESMO 2017 Congress in Madrid (1) show that socio-psychological factors...
LUGANO-MADRID, 9 September, 2017 - A new tool to identify patients who would benefit from early palliative care will be presented at the ESMO 2017...
LUGANO-MADRID, 9 September 2017 - Factors that limit the work ability of young adult cancer survivors are reported today at the ESMO 2017 Congress in...
Milan, Italy: Respiratory tract infections in young children are linked to an increased risk of asthma and worse lung function in later life, according to...
New research led by American Cancer Society researchers finds that after full implementation of the Affordable Care Act (ACA), the percent of uninsured decreased substantially...
LUGANO-MADRID, 8 September, 2017 - Rucaparib maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer by 77%, according to late-breaking results from the...
LUGANO-MADRID, 8 September, 2017 - Patients with high risk prostate cancer starting long-term hormone therapy may benefit from two new treatments, according to late-breaking results...
LUGANO-MADRID, 8 September, 2017 - The superiority of docetaxel based triplet therapy over standard care in patients with resectable oesophago-gastric cancer has been confirmed in...
LUGANO-MADRID, 8 September, 2017 - Pembrolizumab has shown a promising response rate in patients with pretreated metastatic gastric cancer, according to late-breaking results from the...
Credit: Perelman School of Medicine, University of Pennsylvania PHILADELPHIA--M. Celeste Simon, PhD, who studies cancer cell metabolism, tumor immunology, and the influence of oxygen availability...
LUGANO-MADRID, 08 September, 2017 - Adding taselisib to letrozole before surgery significantly improved outcomes for patients with early breast cancer that was both estrogen receptor...
Credit: Image: Mariana Muzzopappa, IRB Barcelona Researchers from the Development and Growth Control Laboratory at IRB Barcelona have identified the cell types and molecular mechanism...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.